학술논문
Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study (Allergy, Asthma & Clinical Immunology, (2022), 18, 1, (70), 10.1186/s13223-022-00709-8)
Document Type
Erratum
Author
Source
In: Allergy, Asthma and Clinical Immunology . (Allergy, Asthma and Clinical Immunology, December 2023, 19(1))
Subject
Language
English
ISSN
17101492
17101484
17101484